nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Narrative Review of Sex Differences in Eating Disorders: Is There a Biological Basis?
|
Culbert, Kristen M. |
|
|
43 |
1 |
p. 95-111 |
artikel |
2 |
Binge Eating Disorder: A Psychiatrist's Commentary on Clinical Considerations
|
Citrome, Leslie |
|
|
43 |
1 |
p. 7-16 |
artikel |
3 |
Citicoline as Adjuvant Therapy in Parkinson's Disease: A Systematic Review
|
Que, Diana-Lynn S. |
|
|
43 |
1 |
p. e19-e31 |
artikel |
4 |
Current Therapeutic Approaches to Anorexia Nervosa: State of the Art
|
Muratore, Alexandra F. |
|
|
43 |
1 |
p. 85-94 |
artikel |
5 |
Disordered Eating Is All About Context
|
Jhaveri, Ravi |
|
|
43 |
1 |
p. 1-2 |
artikel |
6 |
Dose Optimization of Vancomycin Using a Mechanism-based Exposure–Response Model in Pediatric Infectious Disease Patients
|
Jung, Woo Jin |
|
|
43 |
1 |
p. 185-194.e16 |
artikel |
7 |
Eating Disorders Update 2021: What We Know, What We Don't Know, and Next Steps
|
Citrome, Leslie |
|
|
43 |
1 |
p. 4-6 |
artikel |
8 |
Editorial Board
|
|
|
|
43 |
1 |
p. ii-iii |
artikel |
9 |
Effects of Postoperative Percutaneous Coronary Intervention, Pharmacologic Treatment, and Predisposing Factors on Clinical Outcomes in Patients With and Without Type 2 Diabetes Along With Critical Limb Ischemia
|
Lee, Chiu-Yang |
|
|
43 |
1 |
p. 195-210.e2 |
artikel |
10 |
Late-stage Product Development and Approvals by Biotechnology Companies After Initial Public Offering, 1997–2016
|
McNamee, Laura M. |
|
|
43 |
1 |
p. 156-171.e15 |
artikel |
11 |
Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study
|
Grilo, Carlos M. |
|
|
43 |
1 |
p. 112-122.e1 |
artikel |
12 |
Psychotherapy and Medications for Eating Disorders: Better Together?
|
Reas, Deborah L. |
|
|
43 |
1 |
p. 17-39 |
artikel |
13 |
Reduced Mortality After Oral Polio Vaccination and Increased Mortality After Diphtheria-tetanus-pertussis Vaccination in Children in a Low-income Setting
|
Øland, Christian Bjerregård |
|
|
43 |
1 |
p. 172-184.e7 |
artikel |
14 |
Regulatory Agilities in the Time of COVID-19: Overview, Trends, and Opportunities
|
Bolislis, Winona Rei |
|
|
43 |
1 |
p. 124-139 |
artikel |
15 |
Short-term Effects of Alfacalcidol on Hospital Length of Stay in Patients Undergoing Valve Replacement Surgery: A Randomized Clinical Trial
|
Naguib, Sandra N. |
|
|
43 |
1 |
p. e1-e18 |
artikel |
16 |
State of the Art: The Therapeutic Approaches to Bulimia Nervosa
|
Hagan, Kelsey E. |
|
|
43 |
1 |
p. 40-49 |
artikel |
17 |
Table of Contents
|
|
|
|
43 |
1 |
p. iv-v |
artikel |
18 |
Tezepelumab Pharmacokinetics, Safety, and Tolerability After Administration via Vial-and-syringe, Accessorized Prefilled Syringe, or Autoinjector: A Randomized Trial in Healthy Volunteers
|
Zheng, Yanan |
|
|
43 |
1 |
p. 142-155.e5 |
artikel |
19 |
The Neurobiology of Binge-eating Disorder Compared with Obesity: Implications for Differential Therapeutics
|
Boswell, Rebecca G. |
|
|
43 |
1 |
p. 50-69 |
artikel |
20 |
Treatment of Eating Disorders in Adults Versus Adolescents: Similarities and Differences
|
Dalle Grave, Riccardo |
|
|
43 |
1 |
p. 70-84 |
artikel |